Please refer letter in relation to reappointment of Managing Director-Dr Ashish Rawandale.
Announcement under Regulation 30 (LODR)-Change in Management
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Tejnaksh Healthcare Ltd. on 6ix
Earlier from Tejnaksh Healthcare
- Tejnaksh Healthcare Ltd. Press Release Apr 28 2025
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Tejnaksh Healthcare Ltd. Press Release Apr 23 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Tejnaksh Healthcare Ltd. Press Release Apr 15 2025
Later from Tejnaksh Healthcare
- Board Meeting Intimation for Audited Result And Any Other Matter With The Permission Of Chair Under Regulation 29 Of SEBI (LODR) Regulations, 2015
- Tejnaksh Healthcare Ltd. Press Release May 23 2025
- Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations AndDisclosure Requirements) Regulations, 2015 And Disclosure Pursuant To Regulation 30.
- Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year Endon 31St March, 2025.
- Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Follow Tejnaksh Healthcare into a list and get an email when it puts out news.
Follow Tejnaksh Healthcare